AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metauk 500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Auk Lifecare Pvt Ltd

Salt Composition

Metformin (500mg)

Overview Metauk 500mg Tablet SR

Metformin 500mg Extended-Release tablets manage type 2 diabetes by regulating blood glucose, mitigating the risk of associated complications. This medication also addresses Polycystic Ovary Syndrome (PCOS) in women. For optimal absorption and to minimize stomach upset, ingest Metformin 500mg ER with food, consistently at the same time daily. Discontinue use only under your physician's guidance. Dietary adherence and regular exercise, as prescribed by your doctor, are crucial for effective diabetes management alongside this medication. Commonly reported side effects include digestive issues (diarrhea, nausea, vomiting, gas, indigestion, abdominal discomfort), fatigue, headache, and decreased appetite. Hypoglycemia (low blood sugar) can occur, especially with concurrent use of other diabetes medications, alcohol consumption, or missed meals; regular blood glucose monitoring is essential. Consult your doctor before starting Metformin 500mg ER if you have pre-existing kidney, liver, or heart conditions, or if you are pregnant or breastfeeding. Pre-treatment kidney function assessment is standard practice. Limit alcohol consumption to reduce the potential for adverse effects.

Primary Ingredients of Metauk 500mg Tablet SR

No text provided. Please provide the text you wish to be rewritten.

Uses of Metauk 500mg Tablet SR

Managing type 2 diabetes and polycystic ovary syndrome (PCOS)

Major Benefits of Metauk 500mg Tablet SR:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metauk 500mg Extended-Release Tablet should be taken with a meal.

Common Side effects of Metauk 500mg Tablet SR:

  • Diarrhea
  • Headache
  • Vomiting
  • Nausea
  • Flatulence
  • Abdominal discomfort
  • Weakness

How to use Metauk 500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take the Metauk 500mg Sustained-Release tablet with a meal.

How Metauk 500mg Tablet SR works:

Metformin 500mg extended-release tablets are a biguanide-class antidiabetic drug. Their mechanism involves reducing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Metauk 500mg SR tablets is inadvisable.

PregnancyPregnancySAFE IF PRESCRIBED

The extended-release Metauk 500mg tablet is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials are scarce.

Breast feedingBreast feedingCAUTION

Sustained-release Metauk 500mg tablets require careful consideration during lactation. Mothers should temporarily discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when taking Metauk 500mg SR tablets; dosage modification may be necessary. Consult a physician for guidance. Metauk 500mg SR tablets are contraindicated in individuals with severe kidney disease.

LiverLiverUNSAFE

Patients with liver conditions should likely avoid Metauk 500mg SR tablets, as their use may be unsafe. A physician's advice is recommended.

What if you forget to take Metauk 500mg Tablet SR :

Should you forget a Metauk 500mg Tablet SR dose, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Metauk 500mg Tablet SR

LabelValue
Type of Compound Guanidine-based hypoglycemic agent
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Metauk 500mg Tablet SR

Individuals with type 2 diabetes exhibit impaired responsiveness to endogenous insulin. Consequently, blood glucose levels elevate. Metauk 500mg Tablet SR employs a multifaceted approach to lower hyperglycemia. This medication reduces hepatic glucose production, diminishes intestinal glucose absorption postprandially, and enhances insulin sensitivity in peripheral tissues. This combined action facilitates improved glucose uptake from the bloodstream and augments the body's natural insulin response.
Metauk 500mg SR tablets have demonstrated weight reduction in overweight and obese patients. This weight loss effect may also be observed in overweight and obese individuals predisposed to diabetes. Furthermore, individuals with insulin sensitivity or resistance may experience weight loss. However, self-initiation of Metauk 500mg SR tablets for weight management is discouraged; physician consultation is mandatory.
Metformin 500mg extended-release tablets are frequently a first-line treatment for patients exhibiting hyperglycemia. This medication aids in blood glucose regulation by enhancing the body's sensitivity to pancreatic insulin, reducing hepatic glucose production, and limiting intestinal glucose absorption. In contrast to other oral hypoglycemics, monotherapy with Metformin 500mg extended-release tablets infrequently leads to hypoglycemia due to its mechanism of action, which avoids excessive insulin secretion. Beyond its efficacy in glycemic control, this medication also assists in managing weight.
Metauk 500mg sustained-release tablets generally do not induce drowsiness and are typically well-tolerated. Infrequently, however, Metauk 500mg sustained-release tablets may lead to sleep disturbances or insomnia. Somnolence can be a symptom of a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Seek medical attention if fatigue or sleepiness develops during Metauk 500mg sustained-release tablet use.
Administer Metauk 500mg sustained-release tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily regimens, consume with breakfast. Twice-daily prescriptions should be divided between morning and evening meals. Three times daily, distribute doses with breakfast, lunch, and dinner. Consuming Metauk 500mg SR with food mitigates potential gastrointestinal distress, including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their endogenous insulin. This leads to elevated blood glucose concentrations. Metauk 500mg Tablet SR employs a multi-faceted approach to lower these elevated blood sugar levels. It reduces hepatic glucose production, diminishes intestinal glucose absorption postprandially, and enhances insulin sensitivity in tissues and organs. This combined action facilitates improved glucose uptake from the bloodstream. Furthermore, it promotes a more effective response to naturally produced insulin.
Metauk 500mg SR tablets have demonstrated weight reduction in overweight and obese patients. This effect may also be observed, albeit modestly, in overweight and obese individuals predisposed to diabetes. Furthermore, weight loss can occur in those with insulin sensitivity or resistance issues. However, self-medicating with this drug for weight management is inadvisable; physician consultation is essential.
Metformin 500mg extended-release tablets are frequently a primary treatment for individuals with elevated blood glucose. This medication manages blood sugar by enhancing the body's insulin sensitivity, reducing hepatic glucose production, and diminishing intestinal glucose absorption. Differing from other oral hypoglycemics, Metformin 500mg extended-release tablets, when used as monotherapy, infrequently lead to hypoglycemia due to their mechanism that avoids excessive insulin release. Beyond its efficacy in glycemic control, this medication also aids in weight management.
Metauk 500mg extended-release tablets generally do not induce drowsiness and are typically well-tolerated. Infrequently, however, Metauk 500mg extended-release tablets may lead to sleep disturbances or insomnia. Somnolence can be a symptom of a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Seek medical attention if fatigue or sleepiness develops during Metauk 500mg extended-release tablet use.
Administer Metauk 500mg sustained-release tablets with or following a meal. Avoid crushing or chewing the tablets; ingest them whole with water. For once-daily prescriptions, consume the tablet in the morning with breakfast. For twice-daily prescriptions, take one tablet with breakfast and the other with dinner. Three times daily, take one tablet with breakfast, lunch, and dinner. Consuming Metauk 500mg sustained-release tablets with food mitigates potential gastrointestinal distress including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their endogenous insulin. Consequently, blood glucose levels rise. Metauk 500mg Tablet SR employs a multifaceted approach to lower elevated blood sugar. It reduces hepatic glucose production, diminishes postprandial intestinal glucose absorption, and enhances insulin sensitivity in tissues. This combined action facilitates improved glucose uptake from the bloodstream and optimizes the body's natural insulin response.
Metauk 500mg SR tablets have demonstrated weight reduction in overweight and obese patients. This weight loss effect may also be observed in overweight and obese individuals predisposed to diabetes. Furthermore, individuals with insulin sensitivity or resistance may experience weight loss. However, self-medicating with this drug for weight management is inadvisable; physician consultation is essential.
Metformin 500mg extended-release tablets are frequently among the initial treatments prescribed for hyperglycemia. This medication aids in blood glucose regulation by enhancing the body's insulin sensitivity, reducing hepatic glucose production, and limiting intestinal glucose absorption. In contrast to other oral hypoglycemics, monotherapy with Metformin 500mg extended-release tablets seldom results in hypoglycemia due to its mechanism that avoids excessive pancreatic insulin release. Beyond its efficacy in glycemic control, it also contributes to weight management.
Metauk 500mg sustained-release tablets generally don't induce drowsiness and are typically well-received. Infrequently, though, Metauk 500mg SR tablets can lead to sleep disturbances or insomnia. Somnolence might signal a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Consult your physician if fatigue or sleepiness develops during Metauk 500mg SR treatment.
Administer Metauk 500mg sustained-release tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily regimens, consume the tablet in the morning with breakfast. Twice-daily prescriptions should be divided, one with breakfast, the other with dinner. For thrice-daily use, distribute doses among breakfast, lunch, and dinner. Ingesting Metauk 500mg SR tablets with food mitigates potential gastrointestinal distress such as indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Metauk 500mg Tablet SR
16
MRP 19
15% off